Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q9Y657
UPID:
SPIN1_HUMAN
Alternative names:
Ovarian cancer-related protein; Spindlin1
Alternative UPACC:
Q9Y657; A8K0X6; B3KRQ4; Q7KZJ8; Q9GZT2; Q9H0N7
Background:
Spindlin-1, also known as Ovarian cancer-related protein and Spindlin1, is a chromatin reader that binds histone H3 at specific methylation marks, activating the Wnt signaling pathway. This protein is implicated in cancer proliferation, chromosomal instability, and the regulation of rRNA gene expression. It also plays a crucial role in the transition from gamete to embryo, influencing oocyte meiotic resumption.
Therapeutic significance:
Understanding the role of Spindlin-1 could open doors to potential therapeutic strategies.